PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Fort Collins, Colorado, USA.\', \'Center for Surveillance, Epidemiology, and Laboratory Services, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.\', \'National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.\', \'New York City Department of Health and Mental Hygiene, Long Island City, New York, New York, USA.\', \'Region 2 South Healthcare Coalition, Romulus, Michigan, USA.\', \'National Center for Health Statistics, Centers for Disease Control and Prevention, Hyattsville, Maryland, USA.\', \'US Public Health Service, Rockville, Maryland, USA.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1093/cid/ciaa1685
?:doi
?:hasPublicationType
?:journal
  • Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
is ?:pmid of
?:pmid
?:pmid
  • 33147319
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Lack of Antibodies to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in a Large Cohort of Previously Infected Persons.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all